LivaNova (FRA:LIA) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LIA LivaNova PLC FRA:LIA
76 GF Score
Price €68.00
GF Value €54.88
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is LivaNova Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


LivaNova  (FRA:LIA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


LivaNova Cyclically Adjusted PS Ratio Related Terms


LivaNova Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for LivaNova's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova Cyclically Adjusted PS Ratio Chart

LivaNova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.00 2.32

LivaNova Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.71 1.94 2.23 2.26 3.08

FRA:LIA vs ITGR, HAE, IRTC: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, LivaNova's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LivaNova Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LivaNova's Cyclically Adjusted PS Ratio falls into.


FRA:LIA
76GF Score
LivaNova PLC FRA:LIA
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LivaNova Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

LivaNova's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, LivaNova's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.97/142.3000*142.3000
=5.970

Current CPI (Jun. 2026) = 142.3000.

LivaNova Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 5.391 101.500 7.558
201612 5.939 102.200 8.269
201703 4.417 102.700 6.120
201706 4.813 103.500 6.617
201709 4.411 104.300 6.018
201712 4.905 105.000 6.647
201803 4.142 105.100 5.608
201806 4.891 105.900 6.572
201809 4.810 106.600 6.421
201812 5.366 107.100 7.130
201903 4.578 107.000 6.088
201906 5.103 107.900 6.730
201909 4.949 108.400 6.497
201912 5.367 108.500 7.039
202003 4.512 108.600 5.912
202006 3.404 108.800 4.452
202009 4.225 109.200 5.506
202012 4.653 109.400 6.052
202103 4.218 109.700 5.471
202106 4.487 111.400 5.732
202109 4.164 112.400 5.272
202112 4.433 114.700 5.500
202203 3.952 116.500 4.827
202206 4.410 120.500 5.208
202209 4.684 122.300 5.450
202212 5.012 125.300 5.692
202303 4.555 126.800 5.112
202306 5.003 129.400 5.502
202309 4.871 130.100 5.328
202312 5.312 130.500 5.792
202403 4.966 131.600 5.370
202406 5.421 133.000 5.800
202409 5.305 133.500 5.655
202412 5.515 135.100 5.809
202503 5.532 136.100 5.784
202506 5.685 138.400 5.845
202509 5.551 138.900 5.687
202512 5.587 139.900 5.683
202603 5.535 140.800 5.594
202606 5.970 142.300 5.970

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is LivaNova (FRA:LIA) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of €68.00 is trading 23.9% above its estimated GF Value™ of €54.88. GuruFocus considers LivaNova to be Modestly Overvalued.

Key valuation signals for FRA:LIA:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €54.88 vs. price of €68.00 (23.9% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the FRA:LIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LivaNova Business Description

Other Exchanges LIVN:USA
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
76GF Score

Get the complete analysis for FRA:LIA

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.00
Price
€54.88
GF Value